Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials

BACKGROUND: Fatigue is a multifactorial symptom commonly reported by patients with prostate cancer as a result of disease and treatment. This study assesses the impact enzalutamide has on patient-reported fatigue (“fatigue”) by using patient-reported outcomes from four pivotal, placebo-controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tombal, Bertrand F., Freedland, Stephen J., Armstrong, Andrew J., Beer, Tomasz M., Stenzl, Arnulf, Sternberg, Cora N., Hussain, Maha, Ganguli, Arijit, Ramaswamy, Krishnan, Bhadauria, Hemant, Ivanescu, Cristina, Turnbull, James, Holmstrom, Stefan, Saad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184276/
https://www.ncbi.nlm.nih.gov/pubmed/34518652
http://dx.doi.org/10.1038/s41391-021-00447-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184276/
https://www.ncbi.nlm.nih.gov/pubmed/34518652
http://dx.doi.org/10.1038/s41391-021-00447-9

Ejemplares similares